Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells.

Liao H, Xiao Y, Hu Y, Xiao Y, Yin Z, Liu L.

Oncol Lett. 2015 Oct;10(4):2055-2062. Epub 2015 Jul 30.

2.

Detection and Characterization of Metastatic Cancer Cells in the Mesogastrium of Gastric Cancer Patients.

Xie D, Liu L, Osaiweran H, Yu C, Sheng F, Gao C, Hu J, Gong J.

PLoS One. 2015 Nov 13;10(11):e0142970. doi: 10.1371/journal.pone.0142970. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0148681.

3.

Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.

Min J, Liu L, Li X, Jiang J, Wang J, Zhang B, Cao D, Yu D, Tao D, Hu J, Gong J, Xie D.

Sci Rep. 2015 Nov 13;5:16578. doi: 10.1038/srep16578.

4.

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.

Yun EJ, Zhou J, Lin CJ, Hernandez E, Fazli L, Gleave M, Hsieh JT.

Clin Cancer Res. 2016 Feb 1;22(3):670-9. doi: 10.1158/1078-0432.CCR-15-0190. Epub 2015 Oct 21.

PMID:
26490309
5.

The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer.

Wang J, Zhu X, Hu J, He G, Li X, Wu P, Ren X, Wang F, Liao W, Liang L, Ding Y.

Oncotarget. 2015 Sep 29;6(29):27427-39. doi: 10.18632/oncotarget.4861.

6.

A Novel Monoclonal Antibody Against Human DAB2IP.

Xu H, Wei D, Xue J, Hu L.

Monoclon Antib Immunodiagn Immunother. 2015 Aug;34(4):251-6. doi: 10.1089/mab.2015.0011.

PMID:
26301928
7.

AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis.

Ji W, Li Y, He Y, Yin M, Zhou HJ, Boggon TJ, Zhang H, Min W.

Cancer Res. 2015 Sep 1;75(17):3492-504. doi: 10.1158/0008-5472.CAN-15-0088. Epub 2015 Jul 2.

PMID:
26139244
8.
9.

Expression of mouse Dab2ip transcript variants and gene methylation during brain development.

Salami F, Qiao S, Homayouni R.

Gene. 2015 Aug 15;568(1):19-24. doi: 10.1016/j.gene.2015.05.012. Epub 2015 May 7.

PMID:
25958345
10.

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors.

Malik S, Villanova L, Tanaka S, Aonuma M, Roy N, Berber E, Pollack JR, Michishita-Kioi E, Chua KF.

Sci Rep. 2015 Apr 29;5:9841. doi: 10.1038/srep09841.

11.

Dab2IP Regulates Neuronal Positioning, Rap1 Activity and Integrin Signaling in the Developing Cortex.

Qiao S, Homayouni R.

Dev Neurosci. 2015;37(2):131-41. doi: 10.1159/000369092. Epub 2015 Feb 25.

PMID:
25721469
12.

Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion.

Nolan KD, Franco OE, Hance MW, Hayward SW, Isaacs JS.

J Biol Chem. 2015 Mar 27;290(13):8271-82. doi: 10.1074/jbc.M115.637496. Epub 2015 Feb 10.

PMID:
25670862
13.

Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells.

Gajula RP, Chettiar ST, Williams RD, Nugent K, Kato Y, Wang H, Malek R, Taparra K, Cades J, Annadanam A, Yoon AR, Fertig E, Firulli BA, Mazzacurati L, Burns TF, Firulli AB, An SS, Tran PT.

Neoplasia. 2015 Jan;17(1):16-31. doi: 10.1016/j.neo.2014.10.009.

14.

Role of epithelial mesenchymal transition in prostate tumorigenesis.

Khan MI, Hamid A, Adhami VM, Lall RK, Mukhtar H.

Curr Pharm Des. 2015;21(10):1240-8. Review.

15.

Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.

Xu G, Yu H, Shi X, Sun L, Zhou Q, Zheng D, Shi H, Li N, Zhang X, Shao G.

BMC Pulm Med. 2014 Nov 7;14:174. doi: 10.1186/1471-2466-14-174.

16.

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression.

Grant CM, Kyprianou N.

Transl Androl Urol. 2013 Sep 1;2(3):202-211.

17.

The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.

Tsai YS, Lai CL, Lai CH, Chang KH, Wu K, Tseng SF, Fazli L, Gleave M, Xiao G, Gandee L, Sharifi N, Moro L, Tzai TS, Hsieh JT.

Oncotarget. 2014 Aug 15;5(15):6425-36.

18.

Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Beck TN, Chikwem AJ, Solanki NR, Golemis EA.

Physiol Genomics. 2014 Oct 1;46(19):699-724. doi: 10.1152/physiolgenomics.00062.2014. Epub 2014 Aug 5. Review.

19.

Carnosic acid inhibits the epithelial-mesenchymal transition in B16F10 melanoma cells: a possible mechanism for the inhibition of cell migration.

Park SY, Song H, Sung MK, Kang YH, Lee KW, Park JH.

Int J Mol Sci. 2014 Jul 17;15(7):12698-713. doi: 10.3390/ijms150712698.

20.

Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin.

Lai CH, Chang CS, Liu HH, Tsai YS, Hsu FM, Yu YL, Lai CK, Gandee L, Pong RC, Hsu HW, Yu L, Saha D, Hsieh JT.

Oncotarget. 2014 Jul 30;5(14):5523-34.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk